Zhejiang Garden Biopharmaceutical Co Ltd
300401
Company Profile
Business description
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Contact
No. 166, Street 20
Economic & Technological Development Zone
Zhejiang
Hangzhou310018
CHNT: +86 57186571196
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,163
Stocks News & Analysis
stocks
This ASX miner is the cheapest in our iron ore coverage
High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks
Apple names new CEO as Tim Cook steps aside after 15 years
John Ternus, Apple’s hardware chief, will take up the role in September.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,074.40 | 50.80 | -0.56% |
| CAC 40 | 8,156.43 | 79.28 | -0.96% |
| DAX 40 | 24,194.90 | 75.97 | -0.31% |
| Dow JONES (US) | 49,490.03 | 340.65 | 0.69% |
| FTSE 100 | 10,476.46 | 21.63 | -0.21% |
| HKSE | 26,163.24 | 324.24 | -1.22% |
| NASDAQ | 24,657.57 | 397.60 | 1.64% |
| Nikkei 225 | 59,585.86 | 236.69 | 0.40% |
| NZX 50 Index | 12,945.60 | 13.27 | 0.10% |
| S&P 500 | 7,137.90 | 73.89 | 1.05% |
| S&P/ASX 200 | 8,843.60 | 53.20 | -0.60% |
| SSE Composite Index | 4,106.26 | 21.18 | 0.52% |